Des-gamma-carboxy prothrombin (DCP) level is a strong factor to predict the prognosis of advanced stage of hepatocellular carcinoma patients treated by chemolipiodolization or chemotherapy only.

被引:0
|
作者
Ohnishi, H
Sakaguchi, K
Nishda, T
Iwadou, S
Shoji, B
Tanaka, H
Nakamura, S
Kobayashi, Y
Noose, K
Shiratori, Y
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A453 / A453
页数:1
相关论文
共 50 条
  • [1] Des-gamma-carboxy prothrombin (DCP) as a prognostic biomarker in patients with advanced hepatocellular carcinoma treated with atezolizumab/bevacizumab.
    Conner, Elizabeth
    Chang, Jeremy
    Burgoyne, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Des-gamma-carboxy prothrombin (DCP) as a biomarker for treatment response in hepatocellular carcinoma.
    Conner, Elizabeth
    Chang, Jeremy
    Burgoyne, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 547 - 547
  • [3] Des-gamma-carboxy prothrombin is an autologous growth factor for hepatocellular carcinoma
    Shiraha, H.
    Suzuki, M.
    Fujikawa, T.
    Ueda, N.
    Takaoka, N.
    Nakanishi, Y.
    Takaki, A.
    Shiratori, Y.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S117 - S117
  • [4] Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells
    Zhang, Yu-Sheng
    Chu, Jia-Hui
    Song, Zhi-Yu
    Cui, Shu-Xiang
    Qu, Xian-Jun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (01) : 201 - 212
  • [5] Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
    Kenichi Hakamada
    Norihisa Kimura
    Takuya Miura
    Hajime Morohashi
    Keinosuke Ishido
    Masaki Nara
    Yoshikazu Toyoki
    Shunji Narumi
    Mutsuo Sasaki
    World Journal of Gastroenterology, 2008, (09) : 1370 - 1377
  • [6] High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular Carcinoma
    Kobayashi, Masahiro
    Ikeda, Kenji
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Kumada, Hiromitsu
    CANCER, 2009, 115 (03) : 571 - 580
  • [7] Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
    Hakamada, Kenichi
    Kimura, Norihisa
    Miura, Takuya
    Morohashi, Hajime
    Ishido, Keinosuke
    Nara, Masaki
    Toyoki, Yoshikazu
    Narumi, Shunji
    Sasaki, Mutsuo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (09) : 1370 - 1377
  • [8] Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria
    Takanori Sakaguchi
    Shohachi Suzuki
    Yoshifumi Morita
    Kousuke Oishi
    Atsushi Suzuki
    Kazuhiko Fukumoto
    Keisuke Inaba
    Satoshi Nakamura
    Hiroyuki Konno
    Surgery Today, 2010, 40 : 638 - 645
  • [9] Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria
    Sakaguchi, Takanori
    Suzuki, Shohachi
    Morita, Yoshifumi
    Oishi, Kousuke
    Suzuki, Atsushi
    Fukumoto, Kazuhiko
    Inaba, Keisuke
    Nakamura, Satoshi
    Konno, Hiroyuki
    SURGERY TODAY, 2010, 40 (07) : 638 - 645
  • [10] POSTABLATION DES-GAMMA-CARBOXY PROTHROMBIN: PREDICTION OF PROGNOSIS IN HEPATITIS B-RELATED HEPATOCELLULAR CARCINOMA
    Lee, S.
    Rhim, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S342 - S342